Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)
Clinical trial NCT03547154 · TERMINATED
Trial details
- NCT number
- NCT03547154
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-10-22
- Primary completion
- 2001-02-20
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.